ClinConnect ClinConnect Logo
Search / Trial NCT06795542

The Aim of Study is to Identify the Predictive Factors for the Success of Transforaminal Epidural Injection in Treatment of Patients with Lumbosacral Radiculopathy

Launched by AMR MOHAMED SEDIK · Jan 27, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Predictive Factors Transforaminal Epidural Injection

ClinConnect Summary

Lumbar radicular pain (known as sciatica) represents a prevalent medical and socioeconomic problem.

More than half of the patients with sciatica report a decline in their activities of daily living and ability to work.

Mixed Pathologies as foraminal stenosis, spondylolisthesis, and space-occupying lesions in the lumbar spine can cause Sciatica but the most common cause is lumbar disc herniation. (1) Overall, the vast majority of patients with lumbosacral radiculopathy recover with conservative care as trial of bed rest, oral medications, lumbar corsets and physiotherapy. (2) The involveme...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - 1.Patients who underwent lumbosacral transforaminal epidural injection at the level of L4-5, L5-S1, or S1 neural foramina 2.Patients age 18 to 60 years 3.Patients had been symptomatic longer than 6 Weeks with Leg pain more than back pain with failure conservative treatment.
  • 4.Patients had undergone an MRI Lumbosacral imaging scan documenting disc prolapse
  • Exclusion Criteria:
  • 1- Patients had previous lumbar surgery 2- Patients had a large herniated disc with severe central or foraminal stenosis on magnetic resonance imaging 3- Patients had Scoliosis , spondylolisthesis or malignancy 4- patients with neurological deficit. 5-Patients had a blood coagulation disorder, or had experienced an allergic reaction to local anesthetics or corticosteroids.

About Amr Mohamed Sedik

Amr Mohamed Sedik is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on developing and evaluating novel therapeutic interventions, Sedik's initiatives emphasize rigorous scientific methodology, ethical standards, and patient safety. The organization collaborates with leading healthcare professionals and institutions to ensure the successful design, execution, and management of clinical trials, while fostering a culture of transparency and integrity in all research activities. Through these efforts, Sedik aims to contribute significantly to the fields of medicine and healthcare, ultimately enhancing the quality of life for patients worldwide.

Locations

Sohag, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported